(S (NP (DT The) (NML (NN COVID) (HYPH -) (CD 19)) (NN pandemic)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT a) (JJ major) (NN challenge)) (PP (IN to) (NP (NN humanity)))) (, ,) (PP (IN with) (NP (NP (QP (CD 12.7) (CD million))) (SBAR (S (VP (VBD confirmed) (NP (NNS cases)) (PP (IN as) (FRAG (PP (IN of) (NP (NNP July))) (NP-TMP (NN 13th)) (, ,) (NP (CD 2020)))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))))))))) (. .))
(S (PP (IN In) (NP (JJ previous) (NN work))) (, ,) (NP (PRP we)) (VP (VBD described) (SBAR (WHADVP (WRB how)) (S (NP (NNP Artificial) (NNP Intelligence)) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB tackle) (NP (DT the) (NN pandemic)) (PP (IN with) (NP (NP (NNS applications)) (PP (IN at) (NP (DT the) (ADJP (JJ molecular) (, ,) (JJ clinical) (, ,) (CC and) (JJ societal)) (NNS scales)))))))) (PRN (-LRB- [) (NP (CD 2)) (-RRB- ])))))))) (. .))
(S (PP (IN In) (NP (DT the) (JJ present) (NML (NN follow) (HYPH -) (NN up)) (NN article))) (, ,) (NP (PRP we)) (VP (VP (VBP review) (NP (DT these) (CD three) (NN research) (NNS directions))) (, ,) (CC and) (VP (VB assess) (NP (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN maturity) (CC and) (NN feasibility))) (PP (IN of) (NP (NP (DT the) (NNS approaches)) (VP (VBN used))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (PRP$ their) (NN potential)) (PP (IN for) (NP (NN operationalization))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VB summarize) (NP (NP (NP (DT some) (ADJP (RB commonly) (VBN encountered)) (NNS risks)) (CC and) (NP (JJ practical) (NNS pitfalls))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NNS guidelines)) (CC and) (NP (NP (JJS best) (NNS practices)) (PP (IN for) (S (VP (VBG formulating) (CC and) (VBG deploying) (NP (NN AI) (NNS applications)) (PP (IN at) (NP (JJ different) (NNS scales)))))))))) (. .))
